Wilson Ye

Wilson Ye is the Vice President and General Manager of CTI in China. Wilson has over fifteen years of experience in the pharmaceutical and biotech industry. Prior to joining CTI, Wilson served as the Regional Sales Director for Myovant Sciences from November 2020 to June 2021. Wilson was responsible for launching Myovant's first product in the United States and managed a team of eight sales representatives.

Before joining Myovant Sciences, Wilson was the Senior Director at Clovis Oncology from October 2016 to November 2020. During their time at Clovis Oncology, they successfully launched two products in the United States and managed a team of fifteen sales representatives.

From September 2010 to October 2016, Wilson worked as the Associate Director for Access, Reimbursement & Distribution Oncology and IPF at Boehringer Ingelheim. In this role, they were responsible for launches of Ofev and Gilotrif, two orphan drugs for the treatment of IPF and Oncology respectively. Wilson also managed national account responsibilities for CVS Health and Humana Specialty.

prior to Boehringer Ingelheim, Wilson worked as a regional director for Gilead Sciences from March 2005 to March 2010. In this role, they were responsible for launching Gilead's first product in the United States and managed a team of eight sales representatives.

Wilson Ye's educational career includes a Bachelor of Science in Sam Walton College of Business: BSBA, Marketing from the University of Arkansas.

They work with Todd Stemler - CFO, Ron Erdahl - EVP, Sales, and Shawn Brown - Eastern Regional Manager. Wilson Ye reports to Griff Reid, CEO.